- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diffuse Cerebral Sclerosis of Schilder
Total 3916 results
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisRussian Federation
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Opexa Therapeutics, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
NeurognosticsTerminatedRelapsing-Remitting Multiple SclerosisUnited States
-
Bristol-Myers SquibbRecruiting
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University Hospital, MontpellierCompletedProgressive Multiple Sclerosis | Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | ControlsFrance
-
University of South FloridaGenentech, Inc.Active, not recruitingPathologic Processes | Nervous System Diseases | Immune System Diseases | Multiple Sclerosis | Demyelinating Diseases | Autoimmune Diseases | Relapsing Remitting Multiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
Johns Hopkins UniversityCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Biogen; Copenhagen University Hospital, Hvidovre; Signifikans...CompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Acceleron Pharma, Inc., a wholly-owned subsidiary...Active, not recruitingSystemic Sclerosis With and Without Interstitial Lung DiseaseUnited States, Canada, Italy, Switzerland
-
Eicos Sciences, Inc.CompletedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited States
-
Eicos Sciences, Inc.CompletedRaynaud Phenomenon Secondary to Systemic SclerosisUnited States
-
Beijing Continent Pharmaceutical Co, Ltd.Shanghai Genomics, Inc.; GNI-EPS Pharmaceuticals, Inc. (GNI Group)UnknownSystemic Sclerosis-associated Interstitial Lung Disease (Ssc-ild)China
-
Poitiers University HospitalNot yet recruitingSystemic Sclerosis | 7.0 Tesla Magnetic Resonance Imaging | Hand Vascular Involvement | Hand Osteoarticular Involvement
-
University Hospital, CaenCompleted
-
Gesynta Pharma ABErgomedCompletedSystemic SclerosisUnited Kingdom, Poland, Belgium, Netherlands
-
Charite University, Berlin, GermanyPhysiomed Elektromedizin AG GermanyCompletedSystemic Sclerosis | Raynaud's PhenomenonGermany
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Bristol-Myers SquibbRecruitingRelapsing-remitting Multiple Sclerosis (RRMS)Spain
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis (RRMS)Italy
-
Polpharma Biologics S.A.CompletedRelapsing-Remitting Multiple Sclerosis (RRMS)Belarus, Ukraine, Georgia, Croatia, Moldova, Republic of, Poland, Serbia
-
CinnagenCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Iran, Islamic Republic of
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedSecondary Progressive Multiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Germans Trias i Pujol HospitalMinisterio de Sanidad, Servicios Sociales e IgualdadCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Spain
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
-
Merck KGaA, Darmstadt, GermanySmerud Medical Research International AS; Merck Serono NorwayCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Norway
-
Rennes University HospitalRecruitingMultiple Sclerosis | Relapsing-remitting Multiple SclerosisFrance
-
Judit PichRecruitingRelapsing-Remitting Multiple SclerosisSpain
-
BiogenActive, not recruitingRelapsing-Remitting Multiple SclerosisItaly, Belgium, United States, Hungary, Sweden, United Kingdom, Israel, France, Czechia, Poland, Serbia, Denmark, Spain, Turkey, Bulgaria, Germany, Canada, Kuwait
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisSpain, Czechia, Bulgaria, Serbia, Russian Federation, Ukraine, Poland, Slovakia
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
Kessler FoundationActive, not recruitingMultiple Sclerosis | Relapsing-remitting Multiple SclerosisUnited States
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom
-
Anokion SAActive, not recruitingRelapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)United States
-
Ohio State UniversityNational Multiple Sclerosis SocietyCompleted
-
Karolinska InstitutetPatient-Centered Outcomes Research Institute; Kaiser Foundation Research InstituteActive, not recruitingRelapsing-remitting Multiple SclerosisSweden
-
BiocadCompletedRelapsing-remitting Multiple Sclerosis
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
Charite University, Berlin, GermanyDr. Carmen Infante-DuarteTerminatedRelapsing-Remitting Multiple SclerosisGermany
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Czechia, Hungary, Austria, Belgium, Canada, Portugal, Slovakia, Slovenia
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany